{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:03:26Z","timestamp":1787915006124,"version":"build-2784847793"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.prp.2024.155725","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T17:01:04Z","timestamp":1732899664000},"page":"155725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Whole genome profiling of primary and metastatic adrenocortical carcinoma unravels significant molecular events"],"prefix":"10.1016","volume":"266","author":[{"given":"Taylor","family":"Kalomeris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majd Al","family":"Assaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus Delgado-de","family":"la Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunes","family":"Gundem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max F.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Boyraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyothi","family":"Manohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sigouros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan S.","family":"Medina-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sboner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Elemento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Scognamiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Miguel","family":"Mosquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.prp.2024.155725_bib1","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: Adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.prp.2024.155725_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.prp.2024.155725_bib3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","article-title":"Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?","volume":"30","author":"Kebebew","year":"2006","journal-title":"World J. Surg."},{"issue":"16","key":"10.1016\/j.prp.2024.155725_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14163904","article-title":"The overall survival and progression-free survival in patients with advanced adrenocortical cancer is increased after the multidisciplinary team evaluation","volume":"14","author":"Tizianel","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.prp.2024.155725_bib5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1530\/EJE-13-0519","article-title":"Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center","volume":"169","author":"Ayala-Ramirez","year":"2013","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"10.1016\/j.prp.2024.155725_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-001-0047-y","article-title":"Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group","volume":"25","author":"Icard","year":"2001","journal-title":"World J. Surg."},{"issue":"3","key":"10.1016\/j.prp.2024.155725_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1097-0142(19890801)64:3<765::AID-CNCR2820640333>3.0.CO;2-I","article-title":"Adrenal cortical carcinoma","volume":"64","author":"Venkatesh","year":"1989","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.prp.2024.155725_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10434-999-0719-7","article-title":"Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma","volume":"6","author":"Schulick","year":"1999","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2024.155725_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/his.13255","article-title":"Challenges in surgical pathology of adrenocortical tumours","volume":"72","author":"Erickson","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2024.155725_bib10","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41379-018-0042-6","article-title":"Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas","volume":"31","author":"Vatrano","year":"2018","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2024.155725_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO Classification of Adrenal Cortical Tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2024.155725_bib12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.prp.2024.155725_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1984","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2024.155725_bib14","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.humpath.2009.03.010","article-title":"The Weiss system for evaluating adrenocortical neoplasms: 25 years later","volume":"40","author":"Lau","year":"2009","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2024.155725_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/106689690401200304","article-title":"Adrenocortical oncocytic tumors: report of 10 cases and review of the literature","volume":"12","author":"Bisceglia","year":"2004","journal-title":"Int J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155725_bib16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.humpath.2014.11.015","article-title":"Helsinki score\u2014a novel model for prediction of metastases in adrenocortical carcinomas","volume":"46","author":"Pennanen","year":"2015","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2024.155725_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9020175","article-title":"Adrenocortical Carcinoma: Updates of Clinical and Pathological Features after Renewed World Health Organisation Classification and Pathology Staging","volume":"9","author":"Lam","year":"2021","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.prp.2024.155725_bib18","first-page":"963","article-title":"An eleven-year experience with adrenocortical carcinoma","volume":"112","author":"Pommier","year":"1992","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.prp.2024.155725_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0039-6060(96)80164-4","article-title":"The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group","volume":"119","author":"Crucitti","year":"1996","journal-title":"Surgery"},{"key":"10.1016\/j.prp.2024.155725_bib20","first-page":"635","article-title":"Current management options for recurrent adrenocortical carcinoma","volume":"6","author":"Glover","year":"2013","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.prp.2024.155725_bib21","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.prp.2024.155725_bib22","article-title":"Whole-genome and transcriptome analysis of advanced adrenocortical cancer highlights multiple alterations affecting epigenome and DNA repair pathways","volume":"8","author":"Lavoie","year":"2022","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"issue":"8","key":"10.1016\/j.prp.2024.155725_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26432","article-title":"Management of adrenal masses in patients with Beckwith-Wiedemann syndrome","volume":"64","author":"MacFarland","year":"2017","journal-title":"Pedia Blood Cancer"},{"issue":"3","key":"10.1016\/j.prp.2024.155725_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1530\/EC-18-0526","article-title":"Adrenocortical carcinoma in patients with MEN1: a kindred report and review of the literature","volume":"8","author":"Wang","year":"2019","journal-title":"Endocr. Connect"},{"issue":"1","key":"10.1016\/j.prp.2024.155725_bib25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/curroncol28010025","article-title":"Genomic and clinical correlates of adrenocortical carcinoma in an adult patient with Li-fraumeni syndrome: a case report","volume":"28","author":"Bondy","year":"2020","journal-title":"Curr. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2024.155725_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF03346515","article-title":"Investigation of BRAF and CTNNB1 activating mutations in adrenocortical tumors","volume":"32","author":"Masi","year":"2009","journal-title":"J. Endocrinol. Invest"},{"issue":"6","key":"10.1016\/j.prp.2024.155725_bib27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat. Genet"},{"issue":"5","key":"10.1016\/j.prp.2024.155725_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.prp.2024.155725_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ecl.2017.01.007","article-title":"Genetics of adrenocortical development and tumors","volume":"46","author":"Lodish","year":"2017","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"1","key":"10.1016\/j.prp.2024.155725_bib30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.surg.2020.05.039","article-title":"Molecular genomic profiling of adrenocortical cancers in clinical practice","volume":"169","author":"Darabi","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.prp.2024.155725_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12920-020-00809-7","article-title":"Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape","volume":"13","author":"Fojo","year":"2020","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.prp.2024.155725_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.613248","article-title":"Current status and future targeted therapy in adrenocortical cancer","volume":"12","author":"Alyateem","year":"2021","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.prp.2024.155725_bib33","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1038\/s41467-022-30233-7","article-title":"Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers","volume":"13","author":"Shukla","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.prp.2024.155725_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/PAS.0000000000002159","article-title":"NIPBL::NACC1 Fusion Hepatic Carcinoma","volume":"48","author":"Hissong","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"issue":"7","key":"10.1016\/j.prp.2024.155725_bib35","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a006227","article-title":"Whole-genome characterization of myoepithelial carcinomas of the soft tissue","volume":"8","author":"Cyrta","year":"2022","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"issue":"14","key":"10.1016\/j.prp.2024.155725_bib36","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"7_ement","key":"10.1016\/j.prp.2024.155725_bib37","article-title":"Abstract 2149: A whole genome sequencing classifier of homologous recombination deficiency","volume":"83","author":"Hadi","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2024.155725_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100452","article-title":"Whole-genome sequencing analysis of male breast cancer unveils novel structural events and potential therapeutic targets","author":"Al Assaad","year":"2024","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2024.155725_bib39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2024.155725_bib40","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1038\/ncomms6383","article-title":"The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer","volume":"5","author":"Chakravarty","year":"2014","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.prp.2024.155725_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.prp.2024.155725_bib42","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1101\/gr.132159.111","article-title":"The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression","volume":"22","author":"Derrien","year":"2012","journal-title":"Genome Res"},{"issue":"1","key":"10.1016\/j.prp.2024.155725_bib43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1186\/s12859-020-03879-7","article-title":"Isabl Platform, a digital biobank for processing multimodal patient data","volume":"21","author":"Medina-Mart\u00ednez","year":"2020","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.prp.2024.155725_bib44","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.prp.2024.155725_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz972","article-title":"ClinVar: improvements to accessing data","volume":"48","author":"Landrum","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prp.2024.155725_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.prp.2024.155725_bib47","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.prp.2024.155725_bib48","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","article-title":"Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal","volume":"83","author":"de Bruijn","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2024.155725_bib49","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/s41467-018-06366-z","article-title":"Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors","volume":"9","author":"Gara","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2024.155725_bib50","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-21-0327","article-title":"FDA approval summary: pembrolizumab for the treatment of tumor mutational burden\u2013high solid tumors","volume":"27","author":"Marcus","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2024.155725_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0722-x","article-title":"Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma","volume":"7","author":"Habra","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.prp.2024.155725_bib52","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013517","article-title":"Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden: two case reports","volume":"97","author":"Mota","year":"2018","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.prp.2024.155725_bib53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1530\/ERC-14-0016","article-title":"The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors","volume":"21","author":"Liu","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2024.155725_bib54","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s12022-021-09691-0","article-title":"TERT copy number alterations, promoter mutations and rearrangements in adrenocortical carcinomas","volume":"33","author":"Gupta","year":"2022","journal-title":"Endocr. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2024.155725_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250518","article-title":"LPCAT1-TERT fusions are uniquely recurrent in epithelioid trophoblastic tumors and positively regulate cell growth","volume":"16","author":"Oliver","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.prp.2024.155725_bib56","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.clgc.2021.02.002","article-title":"TERT gene fusions characterize a subset of metastatic leydig cell tumors","volume":"19","author":"Kruslin","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"issue":"8","key":"10.1016\/j.prp.2024.155725_bib57","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1158\/1078-0432.CCR-21-3394","article-title":"Integrated analysis of ovarian juvenile granulosa cell tumors reveals distinct epigenetic signatures and recurrent TERT rearrangements","volume":"28","author":"Vougiouklakis","year":"2022","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.prp.2024.155725_bib58","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004756","article-title":"First case report of an adrenocortical carcinoma caused by a BRCA2 mutation","volume":"95","author":"El Ghorayeb","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.prp.2024.155725_bib59","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1210\/js.2018-00343","article-title":"Case report of an adrenocortical carcinoma associated with germline CHEK2 mutation","volume":"3","author":"Xie","year":"2019","journal-title":"J. Endocr. Soc."},{"issue":"2","key":"10.1016\/j.prp.2024.155725_bib60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/path.4890","article-title":"Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer","volume":"242","author":"Mutter","year":"2017","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2024.155725_bib61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41523-021-00339-0","article-title":"Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination","volume":"7","author":"Setton","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1016\/j.prp.2024.155725_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41523-022-00411-3","article-title":"PARP inhibition in breast cancer: progress made and future hopes","volume":"8","author":"Tung","year":"2022","journal-title":"NPJ Breast Cancer"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824006368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824006368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T11:30:26Z","timestamp":1739273426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824006368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":62,"alternative-id":["S0344033824006368"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155725","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole genome profiling of primary and metastatic adrenocortical carcinoma unravels significant molecular events","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155725"}}